Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sun Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Sun Pharmaceutical Industries Ltd (SUNPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

04 May 2016 Thomson Reuters Stock Report 11 $25.00

Wright Industry Averages: Pharmaceuticals & Biotechnology (India)

Wright Investors' Service Industry Averages - Pharmaceuticals & Biotechnology (India). Wright Industry Averages provide calcu...

26 Apr 2016 Wright Reports 68 $169.00

Wright Investors Service Comprehensive Report for Sun Pharmaceuticals Industries Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

21 Apr 2016 Wright Reports 55 $75.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

13 Apr 2016 GlobalData 154 $300.00

Company Snapshot - Sun Pharmaceuticals Industries

A director at Sun Pharmaceuticals Industries bought 12,100 shares at 0.000INR and the significance rating of the trade was 62...

29 Mar 2016 Directors Deals Ltd. 1 $12.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

09 Mar 2016 GlobalData 149 $300.00

MOSL: Sun Pharma 3QFY16 (Buy)-Strong results-multiple triggers to drive growth

SUN PHARMA 3QFY16: Strong results; multiple triggers to drive growth (SUNP IN, Mkt Cap USD29.9b, CMP INR848, TP INR975, 15% ...

16 Feb 2016 Motilal Oswal Securities Ltd. 14 $138.00

Spark Capital: Sun Pharmaceutical Industries 3QFY16 Outlook Review (TP: Rs. 944; Rating: BUY)

Sun Pharmaceutical Industries 3QFY16 Outlook Review (TP: Rs. 944; Rating: BUY) How does our one year outlook change? W...

15 Feb 2016 Spark Capital Advisors(India) Private Limited 5 $35.00

Sun Pharmaceuticals Industries’ (SUNP IN)_Q3FY16 Result Update

Sun Pharmaceuticals Industries’ (SUNP IN) Sequential improvement in operating margin; Work‐inprogress for resolving regulato...

15 Feb 2016 IndiaNivesh Securities Pvt Ltd 5 $46.00